Mechanisms of neurodegeneration in Huntington's disease
- PMID: 18588526
- DOI: 10.1111/j.1460-9568.2008.06310.x
Mechanisms of neurodegeneration in Huntington's disease
Erratum in
- Eur J Neurosci. 2008 Nov;28(10):2156
Abstract
Huntington's disease (HD) is caused by an expansion of cytosine-adenine-guanine (CAG) repeats in the huntingtin gene, which leads to neuronal loss in the striatum and cortex and to the appearance of neuronal intranuclear inclusions of mutant huntingtin. Huntingtin plays a role in protein trafficking, vesicle transport, postsynaptic signaling, transcriptional regulation, and apoptosis. Thus, a loss of function of the normal protein and a toxic gain of function of the mutant huntingtin contribute to the disruption of multiple intracellular pathways. Furthermore, excitotoxicity, dopamine toxicity, metabolic impairment, mitochondrial dysfunction, oxidative stress, apoptosis, and autophagy have been implicated in the progressive degeneration observed in HD. Nevertheless, despite the efforts of a multidisciplinary scientific community, there is no cure for this devastating neurodegenerative disorder. This review presents an overview of the mechanisms that may contribute for HD pathogenesis. Ultimately, a better understanding of these mechanisms will lead to the development of more effective therapeutic targets.
Similar articles
-
Screening of therapeutic strategies for Huntington's disease in YAC128 transgenic mice.CNS Neurosci Ther. 2012 Jan;18(1):77-86. doi: 10.1111/j.1755-5949.2011.00246.x. CNS Neurosci Ther. 2012. PMID: 21501423 Free PMC article. Review.
-
Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment.Neurobiol Dis. 2005 Dec;20(3):785-98. doi: 10.1016/j.nbd.2005.05.017. Epub 2005 Jul 11. Neurobiol Dis. 2005. PMID: 16006135
-
Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1035-45. doi: 10.1098/rstb.1999.0456. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434303 Free PMC article.
-
Genetic interaction between expanded murine Hdh alleles and p53 reveal deleterious effects of p53 on Huntington's disease pathogenesis.Neurobiol Dis. 2006 Nov;24(2):419-27. doi: 10.1016/j.nbd.2006.08.002. Epub 2006 Sep 15. Neurobiol Dis. 2006. PMID: 16978870 Free PMC article.
-
Selective neuronal degeneration in Huntington's disease.Curr Top Dev Biol. 2006;75:25-71. doi: 10.1016/S0070-2153(06)75002-5. Curr Top Dev Biol. 2006. PMID: 16984809 Review.
Cited by
-
Brain lipidomics: From functional landscape to clinical significance.Sci Adv. 2022 Sep 16;8(37):eadc9317. doi: 10.1126/sciadv.adc9317. Epub 2022 Sep 16. Sci Adv. 2022. PMID: 36112688 Free PMC article. Review.
-
DNA repair mechanisms in Huntington's disease.Mol Neurobiol. 2013 Jun;47(3):1093-102. doi: 10.1007/s12035-013-8409-7. Epub 2013 Jan 30. Mol Neurobiol. 2013. PMID: 23361256 Review.
-
Searching for MIND: microRNAs in neurodegenerative diseases.J Biomed Biotechnol. 2009;2009:871313. doi: 10.1155/2009/871313. Epub 2009 Aug 23. J Biomed Biotechnol. 2009. PMID: 19707536 Free PMC article. Review.
-
CREB: a multifaceted regulator of neuronal plasticity and protection.J Neurochem. 2011 Jan;116(1):1-9. doi: 10.1111/j.1471-4159.2010.07080.x. Epub 2010 Dec 2. J Neurochem. 2011. PMID: 21044077 Free PMC article. Review.
-
Role of Phytoconstituents as PPAR Agonists: Implications for Neurodegenerative Disorders.Biomedicines. 2021 Dec 14;9(12):1914. doi: 10.3390/biomedicines9121914. Biomedicines. 2021. PMID: 34944727 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
